Quest Diagnostics Inc. (DGX)
$
9
8
7
6
5
4
3
2
1
0
9
8
7
6
5
4
3
2
1
0
9
8
7
6
5
4
3
2
1
0
9
8
7
6
5
4
3
2
1
0
9
8
7
6
5
4
3
2
1
0
9
8
7
6
5
4
3
2
1
0
9
8
7
6
5
4
3
2
1
0
9
8
7
6
5
4
3
2
1
0
9
8
7
6
5
4
3
2
1
0
About
Business overview of Quest Diagnostics Inc. (DGX)
Quest Diagnostics is a leading independent provider of diagnostic testing, information, and services in the us. The company generates over 95% of its revenue through clinical testing, anatomic pathology, esoteric testing, and substance abuse testing with specimens collected at its national network of roughly 2,300 patient service centers, as well as multiple doctors offices and hospitals. The firm also runs a much smaller diagnostic solutions segment that provides clinical trials testing, risk-assessment services, and information technology solutions.
Key Insights
Critical company metrics and information
Share Price
$157.35Market Cap
$17.56 BillionTotal Outstanding Shares
111.62 Million SharesTotal Employees
48,000Dividend
$0.75 Per Share QuarterlyIPO Date
December 17, 1996SIC Description
Services-medical LaboratoriesHomepage
https://www.questdiagnostics.com
Historical Stock Splits
If you bought 1 share of DGX before June 21, 2005, you'd have 2 shares today.
Execution Date | Split Amount |
---|---|
June 21, 2005 | 2-for-1 |
Cash Flow Statement
October 1, 2023 to September 30, 2024
Metric | Value |
---|---|
Net Cash Flow | $621.00 Million |
Net Cash Flow From Financing Activities | $1.38 Billion |
Net Cash Flow, Continuing | $621.00 Million |
Net Cash Flow From Investing Activities, Continuing | $-2.16 Billion |
Net Cash Flow From Operating Activities | $1.40 Billion |
Net Cash Flow From Investing Activities | $-2.16 Billion |
Net Cash Flow From Operating Activities, Continuing | $1.40 Billion |
Net Cash Flow From Financing Activities, Continuing | $1.38 Billion |
Income Statement
October 1, 2023 to September 30, 2024
Metric | Value |
---|---|
Diluted Average Shares | $336.00 Million |
Income/Loss From Continuing Operations After Tax | $868.00 Million |
Revenues | $9.54 Billion |
Preferred Stock Dividends And Other Adjustments | $0.00 |
Income/Loss From Continuing Operations Before Tax | $1.11 Billion |
Provision For Loan, Lease, And Other Losses | $0.00 |
Income/Loss Before Equity Method Investments | $1.11 Billion |
Income/Loss From Equity Method Investments | $22.00 Million |
Diluted Earnings Per Share | $7.44 |
Operating Income/Loss | $1.25 Billion |
Nonoperating Income/Loss | $-139.00 Million |
Costs And Expenses | $8.29 Billion |
Basic Earnings Per Share | $7.52 |
Net Income/Loss | $890.00 Million |
Net Income/Loss Attributable To Parent | $841.00 Million |
Income Tax Expense/Benefit, Deferred | $-31.00 Million |
Other Operating Expenses | $159.00 Million |
Interest And Dividend Income, Operating | $24.00 Million |
Net Income/Loss Attributable To Noncontrolling Interest | $49.00 Million |
Interest Income/Expense After Provision For Losses | $-176.00 Million |
Income Tax Expense/Benefit | $245.00 Million |
Benefits Costs and Expenses | $8.43 Billion |
Selling, General, and Administrative Expenses | $1.71 Billion |
Operating Expenses | $1.87 Billion |
Interest Income/Expense Operating, Net | $-176.00 Million |
Basic Average Shares | $334.00 Million |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $4.00 Million |
Gross Profit | $3.12 Billion |
Cost Of Revenue | $6.42 Billion |
Net Income/Loss Available To Common Stockholders, Basic | $841.00 Million |
Balance Sheet
October 1, 2023 to September 30, 2024
Metric | Value |
---|---|
Inventory | $184.00 Million |
Current Assets | $2.62 Billion |
Other Current Assets | $2.44 Billion |
Liabilities | $9.25 Billion |
Noncurrent Assets | $13.47 Billion |
Other Non-current Assets | $9.66 Billion |
Equity Attributable To Noncontrolling Interest | $32.00 Million |
Equity Attributable To Parent | $6.81 Billion |
Long-term Debt | $6.25 Billion |
Liabilities And Equity | $16.09 Billion |
Redeemable Noncontrolling Interest | $80.00 Million |
Assets | $16.09 Billion |
Equity | $6.84 Billion |
Temporary Equity | $80.00 Million |
Fixed Assets | $2.09 Billion |
Intangible Assets | $1.72 Billion |
Current Liabilities | $2.09 Billion |
Noncurrent Liabilities | $7.16 Billion |
Other Non-current Liabilities | $911.00 Million |
Historical Dividends
Current dividend: $0.75 Per Share Quarterly
Announcement Date | Payment Date | Record Date | Amount | Frequency |
---|---|---|---|---|
Nov 12, 2024 | Jan 29, 2025 | Jan 14, 2025 | $0.75 | Quarterly |
Aug 14, 2024 | Oct 21, 2024 | Oct 4, 2024 | $0.75 | Quarterly |
May 15, 2024 | Jul 22, 2024 | Jul 8, 2024 | $0.75 | Quarterly |
Feb 1, 2024 | Apr 22, 2024 | Apr 8, 2024 | $0.75 | Quarterly |
Nov 13, 2023 | Jan 31, 2024 | Jan 17, 2024 | $0.71 | Quarterly |
Aug 14, 2023 | Oct 23, 2023 | Oct 6, 2023 | $0.71 | Quarterly |
May 16, 2023 | Jul 25, 2023 | Jul 11, 2023 | $0.71 | Quarterly |
Feb 2, 2023 | Apr 24, 2023 | Apr 10, 2023 | $0.71 | Quarterly |
Nov 14, 2022 | Feb 1, 2023 | Jan 18, 2023 | $0.66 | Quarterly |
Aug 10, 2022 | Oct 19, 2022 | Oct 4, 2022 | $0.66 | Quarterly |
May 17, 2022 | Jul 20, 2022 | Jul 6, 2022 | $0.66 | Quarterly |
Feb 3, 2022 | Apr 20, 2022 | Apr 6, 2022 | $0.66 | Quarterly |
Nov 17, 2021 | Feb 2, 2022 | Jan 19, 2022 | $0.62 | Quarterly |
Aug 16, 2021 | Oct 20, 2021 | Oct 5, 2021 | $0.62 | Quarterly |
May 20, 2021 | Jul 21, 2021 | Jul 7, 2021 | $0.62 | Quarterly |
Feb 4, 2021 | Apr 21, 2021 | Apr 7, 2021 | $0.62 | Quarterly |
Nov 18, 2020 | Feb 3, 2021 | Jan 20, 2021 | $0.56 | Quarterly |
Aug 18, 2020 | Oct 21, 2020 | Oct 6, 2020 | $0.56 | Quarterly |
May 18, 2020 | Jul 22, 2020 | Jul 8, 2020 | $0.56 | Quarterly |
Jan 30, 2020 | Apr 21, 2020 | Apr 7, 2020 | $0.56 | Quarterly |
Nov 20, 2019 | Jan 29, 2020 | Jan 14, 2020 | $0.53 | Quarterly |
Aug 15, 2019 | Oct 21, 2019 | Oct 4, 2019 | $0.53 | Quarterly |
May 14, 2019 | Jul 22, 2019 | Jul 8, 2019 | $0.53 | Quarterly |
Mar 1, 2019 | Apr 22, 2019 | Apr 8, 2019 | $0.53 | Quarterly |
Nov 28, 2018 | Jan 30, 2019 | Jan 15, 2019 | $0.53 | Quarterly |
Aug 17, 2018 | Oct 22, 2018 | Oct 5, 2018 | $0.5 | Quarterly |
May 14, 2018 | Jul 23, 2018 | Jul 9, 2018 | $0.5 | Quarterly |
Feb 1, 2018 | Apr 18, 2018 | Apr 4, 2018 | $0.5 | Quarterly |
Nov 29, 2017 | Jan 24, 2018 | Jan 9, 2018 | $0.45 | Quarterly |
Aug 18, 2017 | Oct 18, 2017 | Oct 3, 2017 | $0.45 | Quarterly |
May 16, 2017 | Jul 24, 2017 | Jul 10, 2017 | $0.45 | Quarterly |
Feb 21, 2017 | Apr 19, 2017 | Apr 5, 2017 | $0.45 | Quarterly |
Aug 17, 2016 | Oct 19, 2016 | Oct 4, 2016 | $0.4 | Quarterly |
May 18, 2016 | Jul 20, 2016 | Jul 6, 2016 | $0.4 | Quarterly |
Dec 4, 2015 | Jan 27, 2016 | Jan 12, 2016 | $0.38 | Quarterly |
Aug 18, 2015 | Oct 21, 2015 | Oct 6, 2015 | $0.38 | Quarterly |
May 15, 2015 | Jul 22, 2015 | Jul 8, 2015 | $0.38 | Quarterly |
Jan 29, 2015 | Apr 22, 2015 | Apr 8, 2015 | $0.38 | Quarterly |
Dec 4, 2014 | Jan 28, 2015 | Jan 13, 2015 | $0.33 | Quarterly |
Aug 15, 2014 | Oct 22, 2014 | Oct 7, 2014 | $0.33 | Quarterly |
May 21, 2014 | Jul 23, 2014 | Jul 9, 2014 | $0.33 | Quarterly |
Jan 29, 2014 | Apr 23, 2014 | Apr 8, 2014 | $0.33 | Quarterly |
Dec 5, 2013 | Jan 22, 2014 | Jan 7, 2014 | $0.3 | Quarterly |
Aug 20, 2013 | Oct 16, 2013 | Oct 1, 2013 | $0.3 | Quarterly |
May 21, 2013 | Jul 17, 2013 | Jul 2, 2013 | $0.3 | Quarterly |
Feb 26, 2013 | Apr 16, 2013 | Apr 2, 2013 | $0.3 | Quarterly |
Nov 16, 2012 | Jan 28, 2013 | Jan 11, 2013 | $0.3 | Quarterly |
Related Companies
View additional S&P 500 companies similar to Quest Diagnostics Inc. (DGX)
Boost your savings and earn 4.35% APY with a Marcus by Goldman Sachs savings account, a rate that's 8x the national averagewhen signing up with Financhle. No fees, no minimum deposits, backed by the financial expertise of Goldman Sachs. Terms apply.
ⓒ 2024 Financhle. All Rights Reserved.